Distribution of macrophages, osteoclasts and the B-lymphocyte lineage in osteolytic metastasis of mouse mammary carcinoma

Biomedical Research

Volumn 28, Issue 3, 2007, Pages 127-137

  Li, Minqi ^a   Sasaki, Tomoyo ^c   Ono, Katsuhiro ^d   de Freitas, Paulo Henrique Luiz ^a,b   Sobhan, Ubaidus ^a,b   Kojima, Taku ^a,b   Shimomura, Junko ^e   Oda, Kimimitsu ^a,b   Amizuka, Norio ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d JOSAI INTERNATIONAL UNIVERSITY   (Japan)

^e NIPPON DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALKALINE PHOSPHATASE; CD45 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BONE MARROW; BONE METASTASIS; BREAST CARCINOMA; CARCINOMA CELL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; FEMUR; HEART LEFT VENTRICLE; HISTOCHEMISTRY; MACROPHAGE; METAPHYSIS; MONOCYTE; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; TIBIA;

ANIMALS; B-LYMPHOCYTES; BONE NEOPLASMS; CARCINOMA; CELL LINEAGE; FEMALE; MACROPHAGES; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON, TRANSMISSION; OSTEOCLASTS;

MUS;

EID: 34547114472     PISSN: 03886107     EISSN: 1880313X     Source Type: Journal    
DOI: 10.2220/biomedres.28.127     Document Type: Article

References (52)

1. Amizuka N, Yamada M, Watanabe JI, Hoshi K, Fukushi M, Oda K, Ikehara Y and Ozawa H (1998) Morphological examination of bone synthesis via direct administration of basic fibroblast growth factor into rat bone marrow. Microsc Res Tech 41, 313-322.
2. Aoki J, Yamamoto I, Hino M, Shigeno C, Kitamura N, Sone T, Shiomi K and Konishi J (1988) Osteoclast-mediated osteolysis to bone metastasis from renal cell carcinoma. Cancer 62, 98-104.
3. Burstone MS (1958) Histochemical demonstration of acid phosphatases with naphthol AS-phosphates. J Natl Cancer Inst 21, 523-539.
4. Calvani N, Silvestris F, Cafforio P and Dammacco F (2004) Osteoclast-like cell formation by circulateing myeloma B lymphocytes: role of RANK-L. Leuk Lymphoma 45, 377-380.
5. + T cells. Eur J Immunol 31, 2179-2188.
6. Coffman RL and Weissman IL (1981) B220: a B.cell-specific member of the T200 glycoprotein family. Nature 289, 681-683.
7. Coleman RE and Rubens RD (1987) The clinical course of bone metastases from breast cancer. Br J Cancer 55, 61-66.
8. Colucci S, Mori G, Brunetti G, Coricciati M, Pignataro P, Oranger A, Cirulli N, Mastrangelo F, Grassi FR and Grano M (2006) Interleukin-7 production by B lymphocytes affects the T cell-dependent osteoclast formation in an vitro model derived from human periodontitis patients. Int J Immunopathol Pharmacol 19, 13-19.
9. Firusian N, Mellin P and Schmidt CG (1976) Results of 89 strontium therapy in patients with carcinoma of the prostate and incurable pain from bone metastases: a preliminary report. J Urol 116, 764-768.
10. Forster I, Muller W, Schittek B and Rajewsky K (1991) Generation of long-lived B cells in germ-free mice. Eur J Immunol 21, 1779-1782.
11. Galasko CS (1976) Mechanisms of bone destruction in the development of skeletal metastases. Nature 263, 507-508.
12. Garrett IR, Durie BG, Nedwin GE, Gillespie A, Bringman T, Sabatini M, Bertolini DR and Mundy GR (1987) Production of lymphotoxin, a bone-resorbing cytokine, by cultured human myeloma cells. N Engl J Med 317, 526-532.
13. Hall SM, Buzdar AU and Blumenschein GR (1983) Cranial nerve palsies in metastatic breast cancer due to osseous metastasis without intracranial involvement. Cancer 52, 180-184.
14. Han X, Kawai T, Eastcott JW and Taubman MA (2006) Bacterial-Responsive B Lymphocytes Induce Periodontal Bone Resorption. J Immunol 176, 625-631.
15. Hasegawa K, Nishimura H, Ogawa, S, Hirose S, Sato H and Shirai T (1990) Monoclonal antibodies to epitope of CD45R (B220) inhibit interleukin 4-mediated B cell proliferation and differentiation. Int Immunol 2, 367-375.
16. Hipp JA, McBroom RJ, Cheal EJ and Hayes WC (1989) Structural consequences of endosteal metastatic lesions in long bones. J Orthop Res 7, 828-837.
17. Hiraga T, Takada, M, Makajima, T and Ozawa H (1996) Effects of bisphosphonate (pamidronate) on bone resorption resulting from metastasis of a squamous cell carcinoma: report of an autopsy case and evaluation of bone resorting activity in an experimental animal model. J Oral Maxillofac Surg 54, 1327-1333.
18. Iguchi H, Tanaka S, Ozawa, Y, Kashiwakuma T, Kimura T, Hiraga T, Ozawa H and Kono A (1996) An experimental model of bone metastasis by human lung cancer cells: the role of parathyroid hormone-related protein in bone metastasis. Cancer Res 56, 4040-4043.
19. Kanematsu M, Sato T, Takai H, Watanabe K, Ikeda K and Yamada Y (2000) Prostaglandin E2 induces expression of receptor activator of nuclear factor-kappa B ligand/osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency. J Bone Miner Res 15, 1321-1329.
20. Katavic V, Grcevic D, Lee SK, Kalinowski J, Jastrzebski S, Dougall W, Anderson D, Puddington L, Aguila HL and Lorenzo JA (2003) The surface antigen CD45R identifies a population of estrogen-regulated murine marrow cells that contain osteoclast precursors. Bone 32, 581-590.
21. Kindred B (1971) Immunological unresponsiveness of genetically thymusless (nude) mice. Eur J Immunol 1, 59-61.
22. Kondo Y, Irie K, Ikegame M, Ejiri S, Hanada K and Ozawa H (2001) Role of stromal cells in osteoclast differentiation in bone marrow. J Bone Miner Metab 19, 352-358.
23. Kukita A, Kukita T, Shin JH and Kohashi O (1993) Induction of mononuclear precursor cells with osteoclastic pheno-types in a rat bone marrow culture system depleted of stromal cells. Biochem Biophys Res Commun 196, 1383-1389.
24. Leclerc C, Przewlocki G, Schutze, MP and Chedid L (1987) A synthetic vaccine constructed by copolymerization of B and T cell determinants. Eur J Immunol 17, 269-273.
25. Li M, Amizuka N, Takeuchi K, Freitas PH, Kawano Y, Hoshino M, Oda K, Nozawa-Inoue K and Maeda T (2006) Histochemical evidence of osteoclastic degradation of extra-celllar matrix osteolytic metastasis originating from human lung small carcinoma (SBC-5) cells. Microsc Res Tech 69, 73-83.
26. Luikart SD (1988) Degradation of cartilage proteoglycans by myeloid leukemia cells. Exp Hematol 16, 102-105.
27. Manabe N, Kawaguchi H, Chikuda H, Miyaura C, Inada M, Nagai R, Nabeshima Y, Nakamura K, Sinclair AM, Scheuermann RH and Kuro-o M (2001) Connection between B lymphocyte and osteoclast differentiation pathways. J Immunol 167, 2625-2631.
28. Marusic A, Grcevic D, Katavic V, Kovacic N, Lukic IK, Kalajzic I and Lorenzo JA (2000) Role of B lymphocytes in new bone formation. Lab Invest 80, 1761-1774.
29. Medina KL, Smithson G and Kincade PW (1993) Suppression of B lymphopoiesis. during normal pregnancy. J Exp Med 178, 1507-1515.
30. Miyaura C, Onoe Y, Inada M, Maki K, Ikuta K, Ito M and Suda T (1997) Increased B-lymphopoiesis by interleukin 7 induces bone loss in mice with intact ovarian function: similarity to estrogen deficiency. Proc Natl Acad Sci USA 94, 9360-9365.
31. Mojica MP, Perry SS, Searles AE, Elenitoba-Johnson KS, Pierce LJ, Wiesmann A, Slayton WB and Spangrude GJ (2001) Phenotypic distinction and functional characterization of pro-B cells in adult mouse bone marrow. J Immunol 166, 3042-3051.
32. Morimoto J, Imai S, Taniguchi Y, Tsubura Y and Hosick HL (1987) Establishment and characterization of a new murine mammary tumor cell line, BALB/c-MC. In Vitro Cell Dev Biol 23, 755-758.
33. Nango, K, Inaba M, Inaba K, Adachi Y, Than S, Ishida T, Kumamoto T, Uyama M and Ikehara S (1991) Ontogeny of thymic B cells in normal mice. Cell Immunol 133, 109-115.
34. Niida S, Amizuka N, Hara F, Ozawa H and Kodama H (1994) Expression of Mac-2 antigen in the preosteoclast and osteoclast identified in the op/ op mouse injected with macrophage colony-stimulating factor. J Bone Miner Res 9, 873-881.
35. Oda K, Amaya Y, Fukushi-Irie M, Kinameri Y, Ohsuye K, Kubota I, Fujimura S and Kobayashi J (1999) A general method for rapid purification of soluble versions of glycosylphosphatidylinositol-anchored proteins expressed in insect cells: an application for human tissue-nonspecific alkaline phosphatase. J Biochem (Tokyo) 126, 694-699.
36. Ogra PL, Chiba Y, Beutner KR and Morag A (1976) Vaccination by non-parenteral routes: characteristics of immune response. Dev Biol Stand 33, 19-26.
37. Ono K, Akatsu T, Murakami T, Kitamura R, Yamamoto M, Shinomiya N, Rokutanda M, Sasaki T, Amizuka N, Ozawa H, Nagata N and Kugai N (2002) Involvement of cyclo-oxygenase-2 in osteoclast formation and bone destruction in bone metastasis of mammary carcinoma cell lines. J Bone Miner Res 17, 774-781.
38. Ono K, Akatsu T, Murakami T, Wada S, Nishikawa M, Kugai N, Yamamoto M, Matsuura N and Nagata N (1998) Mouse mammary carcinoma cell line (BALB/ c-MC) stimulates osteoclast formation from mouse bone marrow cells through cell-to-cell contact. Bone 23, 27-32.
39. Pollok BA and Kearney JF (1984) Identification and characterization of an apparent germline set of auto-anti-idiotypic regulatory B lymphocytes. J Immunol 132, 114-121.
40. Sato K, Mimura H, Han DC, Kakiuchi T, Ueyama Y, Ohkawa H, Okabe T, Kondo, Y, Ohsawa N and Tsushima T (1986) Production of bone-resorbing activity and colony-stimulating activity in vivo and in vitro by a human squamous cell carcinoma associated with hypercalcemia and leukocytosis. J Clin Invest 78, 145-154.
41. + cells: its role in acdcelerated osteoclastogenesis due to estrogen deficiency. J Bone Miner Res 16, 2215-2221.
42. Shibata H, Abe M, Hiura K, Wilde J, Moriyama K, Sano T, Kitazoe K, Hashimoto T, Ozaki S, Wakatsuki S, Kido S, Inoue D and Matsumoto T (2005) Malignant B-lymphoid cells with bone lesions express receptor activator of nuclear factor-kappaB ligand and vascular endothelial growth factor to enhance osteoclastogenesis. Clin Cancer Res 11, 6109-6115.
43. Shimamura T, Amizuka N, Li M, Freitas PH, White JH, Henderson JE, Shingaki S, Nakajima T and Ozawa H (2005) Histological observations on the microenvironment of osteolytic bone metastasis by breast carcinoma cell line. Biomed Res 26, 159-172.
44. Siclari VA, Guise TA and Chirgwin JM (2006) Molecular interactions between breast cancer cells and the bone microenvironment drive skeletal metastases. Cancer Metastasis Rev 25, 621-633.
45. Thomas RJ, Guise TA, Yin JJ, Elliott J, Horwood NJ, Martin TJ and Gillespie MT (1999) Breast cancer cells interact with osteoblasts to support osteoclast formation. Endocrinology 140, 4451-4458.
46. Thomson BM, Mundy GR and Chambers TJ (1987) Tumor necrosis factors alpha and beta induce osteoblastic cells to stimulate osteoclastic bone resorptiorn. J Immunol 138, 775-779.
47. Urovitz EP, Fornasier VL and Czitrom AA (1977) Sternal metastases and associated pathological fractures, Thorax 32, 444-448.
48. Vascotto F, Le Roux D, Lankar D, Faure-Andre G, Vargas P, Guermonprez P and Lennon-Dumenil AM (2007) Antigen presentation by B lymphocytes: how receptor signaling directs membrane trafficking. Curr Opin Immunol 19, 93-98.
49. Wasserman R, Zeng XX and Hardy RR (1998) The evolution of B precursor leukemia in the Emu-ret mouse. Blood 92, 273-282.
50. Weber KL, Pathak S, Multani AS and Price JE (2002) Characterization of a renal cell carcinoma cell line derived from a human bone metastasis and establishment of an experimental nude mouse model. J Urol 168, 774-779.
51. Westacott CI, Barakat AF, Wood L, Perry MJ, Neison P, Bisbinas I, Armstrong L, Millar AB and Elson CJ (2000) Tumor necrosis factor alpha can contribute to focal loss of cartilage in osteoarthritis. Osteoarthr Cartil 8, 213-221.
52. Yoneda T, Sasaki A and Mundy GR (1994) Osteolytic bone metastasis in breast cancer. Breast Cancer Res Treat 32, 73-84.